SAN FRANCISCO, June 25, 2019  /PRNewswire/ -- The global rabies diagnostics market size is expected to reach USD 2.03 billion by 2025 and is projected to expand at a CAGR of 4.1% during the forecast period, according to a new report by Grand View Research, Inc. Development of various diagnostic assays ranging from detection of virus presence to final confirmation of infection helps launch effective disease control programs. This factor is anticipated to drive the market growth. These assays aid in defining epidemiologic patterns of the disease and thereby deliver appropriate information for designing the control and eradication programs. These programs have boosted the market growth by increasing the rate at which testing kits are adopted.

Key suggestions from the report:

• Fluorescent Antibody Test (FAT) held the largest market share in terms of revenue owing to the high usage and recommendation by the WHO. Great specificity, as compare to other conventional tests such as serology and histology tests bodes well for the adoption of these tests
• Amplification methods are expected to supplant a major portion of conventional methods, primarily due to several advantages associated with the usage
• Currently, major products deploy ELISA/immunohistochemistry techniques, resulting into a larger revenue share of this segment
• High prevalence of the disease in India and China coupled with growing government support has contributed to the dominance of Asia market over other regions
• Since, most of the countries in Europe are designated as rabies free jurisdictions, the Europe market is anticipated to grow at the slowest pace over the forecast period
• Bio-Rad Laboratories, Inc.; Merck KGaA; Aviva Systems Biology Corporation; and Creative Diagnostics are some of the key entities in the rabies testing market. The companies engage in developing products for rabies eradication programs.

Read 110 page research report with TOC on "Rabies Diagnostics Market Size, Share & Trends Analysis Report By Diagnostic Methods (Fluorescent Antibody Test, Histologic, Serology), By Technology (ELISA, PCR), And Segment Forecasts, 2019 - 2025" at: https://www.grandviewresearch.com/industry-analysis/rabies-diagnostics-market

For example, in June 2018, the World Health Organization (WHO), the World Organization for Animal Health (OIE), the Global Alliance for Rabies Control (GARC), and the Food and Agriculture Organization of the United Nations (FAO) entered into a partnership for a plan, The United Against Rabies Collaboration. This plan aims for rabies prevention and management and empowering the under-served populations in afflicted countries.

Furthermore, the state and public health officials of the Department of Public Health and Human Services (DPHHS) along with the Department of Livestock of Montana, U.S., deal with awareness pertaining to the risk of virus exposure. They are engaged in training the population about various aspects of disease management including prevention, detection, and available treatment modes. Such initiatives are projected to create growth opportunities for the rabies diagnostics market during the forecast period.

Grand View Research has segmented the global rabies diagnostics market on the basis of diagnostic method, technology, and region:

• Rabies Diagnostics Diagnostic Method Outlook (Revenue, USD Million, 2014 - 2025)
• Fluorescent antibody test (FAT)
• Immunohistochemical test
• Amplification methods
• Histologic examination
• Serology tests
• Rabies Diagnostics Technology Outlook (Revenue, USD Million, 2014 - 2025)
• ELISA/Immunohistochemistry
• Chromatography techniques
• PCR
• Others
• Rabies Diagnostics Regional Outlook (Revenue, USD Million, 2014 - 2025)
• North America
• U.S.
• Canada
• Europe
• U.K.
• Spain
• Asia Pacific
• India
• China
• Indonesia
• Latin America
• Brazil
• Middle East & Africa
• South Africa

Find more research reports on Clinical Diagnostics Industry, by Grand View Research:

• Endocrine Function Diagnostics Market – The growing prevalence of diabetes will serve the global endocrine function diagnostics market as a significant growth rendering driver.
• Rapid Medical Diagnostic Kits Market – The growing prevalence of cardiovascular diseases, sexually transmitted diseases, diabetes, infectious diseases, hepatitis and gastrointestinal diseases is the most significant driver of the global rapid medical diagnostic kits market.
• Diabetes Treatment Market – The global diabetes treatment market is undergoing significant transition driven by the advent of new analytical technologies and developments in diabetes treatment.

Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com
Follow Us: LinkedIn | Twitter

SOURCE Grand View Research, Inc.